Treatment results, side effects and prognostic factors affecting survival in patients with larynx cancer

ENT Updates

Clinical Research

Treatment results, side effects and prognostic factors affecting survival in patients with larynx cancer

Yücel, B., Ay Eren, A., Erdiş, E., Akgül Babacan, N., & Elif Altuntaş, E. (2013). Treatment results, side effects and prognostic factors affecting survival in patients with larynx cancer. ENT Updates, 3(2). https://doi.org/10.2399/jmu.2013002005

Authors

  • Birsen Yücel

    Department of Radiation Oncology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey
  • Ayfer Ay Eren

    Department of Radiation Oncology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey
  • Eda Erdiş

    Department of Radiation Oncology, Antakya Government Hospital, Hatay, Turkey
  • Nalan Akgül Babacan

    Department of Medical Oncology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey
  • Emine Elif Altuntaş

    Department of Otolaryngology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey

Objective: Our aim was to determine the treatment results, side effects and the prognostic factors affecting survival in patients with larynx cancer treated in our clinic.

Methods: Data of a total of 90 patients with larynx carcinoma were included in the study. The patients’ performance scores were evaluated according to the Eastern Cooperative Oncology Group (ECOG) system.

Results: Eighty-seven (97%) patients were male and three patients (3%) were female. The median age of the patients was 59 (37-86) years. Early-stage, locally advanced stage, and metastatic disease were detected in 43, 55, and 2% of the patients, respectively. Laryngeal cancers were observed in the glottic (53%), and supraglottic (47%) regions. Performance score (p=0.022), grade (p=0.033), lymph node metastasis (p=0.001), T stage (p=0.034) and disease stage (p=0.007) were significantly unfavourable in supraglottic cancers compared to glottic cancers. Recurrence was observed in 17% of the patients in a median 15 (range: 5-96) months. Distant metastasis was observed in 12% of the patients in a median 17 (range: 1-155) months. The factors affecting survival were the presence of comorbidities (p=0.032), performance status (p=0.022), hemoglobin level (p=0.003), T stage (p=0.006), disease stage (p=0.011), and weight loss (p=0.002). When RT- and CRT-associated side effects were compared, the incidence of adverse effects such as mucositis (p<0.001), nausea/vomiting (p<0.001), weight loss (p=0.005), neutropenia (p=0.001), and anemia (p=0.003) in patients under chemoradiotherapy was significantly higher than those associated with radiotherapy.

Conclusion: Hemoglobin level, T stage, presence of comorbidity and weight loss were independent prognostic factors.

Keywords:

Larynx cancer survival prognosis side effect

Most read articles by the same author(s)